 | • レポートコード：20QY06-08192 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、皮膚真菌薬のグローバル市場について種類別（BB-2603、クロトリマゾール、ダパコナゾール、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・皮膚真菌薬市場の概要 ・世界の主要地域別皮膚真菌薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の皮膚真菌薬市場規模2015-2026：種類別（BB-2603、クロトリマゾール、ダパコナゾール、その他） ・世界の皮膚真菌薬市場規模2015-2026：用途別（病院、クリニック、その他） ・皮膚真菌薬の北米市場規模2015-2020 ・皮膚真菌薬のヨーロッパ市場規模2015-2020 ・皮膚真菌薬の中国市場規模2015-2020 ・皮膚真菌薬の日本市場規模2015-2020 ・皮膚真菌薬の東南アジア市場規模2015-2020 ・皮膚真菌薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Anacor Pharmaceuticals Inc、Biolab Farmaceutica Ltda、Blueberry Therapeutics Ltd、Daewoong Pharmaceutical Co Ltd、Dermala Inc、Helix BioMedix Inc、Novan Inc、Sol-Gel Technologies Ltd、TGV-Laboratories、Viamet Pharmaceuticals Inc、Vyome Biosciences Pvt Ltd） ・皮膚真菌薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・皮膚真菌薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Dermatomycoses Drug Market
The global Dermatomycoses Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Dermatomycoses Drug Scope and Market Size
The global Dermatomycoses Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dermatomycoses Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Dermatomycoses Drug market is segmented into
BB-2603
Clotrimazole
Dapaconazole
Others
Segment by Application, the Dermatomycoses Drug market is segmented into
Hospital
Clinic
Others
The Dermatomycoses Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Dermatomycoses Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dermatomycoses Drug Market Share Analysis
Dermatomycoses Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dermatomycoses Drug business, the date to enter into the Dermatomycoses Drug market, Dermatomycoses Drug product introduction, recent developments, etc.
The major vendors covered:
Anacor Pharmaceuticals Inc
Biolab Farmaceutica Ltda
Blueberry Therapeutics Ltd
Daewoong Pharmaceutical Co Ltd
Dermala Inc
Helix BioMedix Inc
Novan Inc
Sol-Gel Technologies Ltd
TGV-Laboratories
Viamet Pharmaceuticals Inc
Vyome Biosciences Pvt Ltd
Table of Contents
1 Dermatomycoses Drug Market Overview
1.1 Dermatomycoses Drug Product Scope
1.2 Dermatomycoses Drug Segment by Type
1.2.1 Global Dermatomycoses Drug Sales by Type (2020-2026)
1.2.2 BB-2603
1.2.3 Clotrimazole
1.2.4 Dapaconazole
1.2.5 Others
1.3 Dermatomycoses Drug Segment by Application
1.3.1 Global Dermatomycoses Drug Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Dermatomycoses Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Dermatomycoses Drug Sales Growth Rate (2015-2026)
1.4.2 Global Dermatomycoses Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Dermatomycoses Drug Price Trends (2015-2026)
2 Dermatomycoses Drug Estimate and Forecast by Region
2.1 Global Dermatomycoses Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Dermatomycoses Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Dermatomycoses Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Dermatomycoses Drug Revenue Market Share by Region (2015-2020)
2.3 Global Dermatomycoses Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Dermatomycoses Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Dermatomycoses Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Dermatomycoses Drug Estimates and Projections (2015-2026)
2.4.2 Europe Dermatomycoses Drug Estimates and Projections (2015-2026)
2.4.3 China Dermatomycoses Drug Estimates and Projections (2015-2026)
2.4.4 Japan Dermatomycoses Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Dermatomycoses Drug Estimates and Projections (2015-2026)
2.4.6 India Dermatomycoses Drug Estimates and Projections (2015-2026)
3 Global Dermatomycoses Drug Competition Landscape by Players
3.1 Global Top Dermatomycoses Drug Players by Sales (2015-2020)
3.2 Global Top Dermatomycoses Drug Players by Revenue (2015-2020)
3.3 Global Dermatomycoses Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatomycoses Drug as of 2019)
3.4 Global Dermatomycoses Drug Average Price by Company (2015-2020)
3.5 Manufacturers Dermatomycoses Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Dermatomycoses Drug Players (Opinion Leaders)
4 Global Dermatomycoses Drug Market Size by Type
4.1 Global Dermatomycoses Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Dermatomycoses Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Dermatomycoses Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Dermatomycoses Drug Price by Type (2014-2020)
4.2 Global Dermatomycoses Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Dermatomycoses Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Dermatomycoses Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Dermatomycoses Drug Price Forecast by Type (2021-2026)
5 Global Dermatomycoses Drug Market Size by Application
5.1 Global Dermatomycoses Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Dermatomycoses Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Dermatomycoses Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Dermatomycoses Drug Price by Application (2015-2020)
5.2 Global Dermatomycoses Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Dermatomycoses Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Dermatomycoses Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Dermatomycoses Drug Price Forecast by Application (2021-2026)
3 North America Dermatomycoses Drug Market Facts & Figures
3.2 North America Dermatomycoses Drug Sales Market Share by Company (2015-2020)
3.3 North America Dermatomycoses Drug Sales Market Share by Type (2015-2020)
3.4 North America Dermatomycoses Drug Sales Market Share by Application (2015-2020)
4 Europe Dermatomycoses Drug Market Facts & Figures
4.2 Europe Dermatomycoses Drug Sales Market Share by Company (2015-2020)
4.3 Europe Dermatomycoses Drug Sales Market Share by Type (2015-2020)
4.4 Europe Dermatomycoses Drug Sales Market Share by Application (2015-2020)
5 China Dermatomycoses Drug Market Facts & Figures
5.2 China Dermatomycoses Drug Sales Market Share by Company (2015-2020)
5.3 China Dermatomycoses Drug Sales Market Share by Type (2015-2020)
5.4 China Dermatomycoses Drug Sales Market Share by Application (2015-2020)
6 Japan Dermatomycoses Drug Market Facts & Figures
6.2 Japan Dermatomycoses Drug Sales Market Share by Company (2015-2020)
6.3 Japan Dermatomycoses Drug Sales Market Share by Type (2015-2020)
6.4 Japan Dermatomycoses Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Dermatomycoses Drug Market Facts & Figures
7.2 Southeast Asia Dermatomycoses Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Dermatomycoses Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Dermatomycoses Drug Sales Market Share by Application (2015-2020)
8 India Dermatomycoses Drug Market Facts & Figures
8.2 India Dermatomycoses Drug Sales Market Share by Company (2015-2020)
8.3 India Dermatomycoses Drug Sales Market Share by Type (2015-2020)
8.4 India Dermatomycoses Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Dermatomycoses Drug Business
12.1 Anacor Pharmaceuticals Inc
12.1.1 Anacor Pharmaceuticals Inc Dermatomycoses Drug Corporation Information
12.1.2 Anacor Pharmaceuticals Inc Dermatomycoses Drug Business Overview and Total Revenue
12.1.3 Anacor Pharmaceuticals Inc Dermatomycoses Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Anacor Pharmaceuticals Inc Dermatomycoses Drug Products Offered
12.1.5 Anacor Pharmaceuticals Inc Recent Development
12.2 Biolab Farmaceutica Ltda
12.2.1 Biolab Farmaceutica Ltda Dermatomycoses Drug Corporation Information
12.2.2 Biolab Farmaceutica Ltda Dermatomycoses Drug Business Overview and Total Revenue
12.2.3 Biolab Farmaceutica Ltda Dermatomycoses Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Biolab Farmaceutica Ltda Dermatomycoses Drug Products Offered
12.2.5 Biolab Farmaceutica Ltda Recent Development
12.3 Blueberry Therapeutics Ltd
12.3.1 Blueberry Therapeutics Ltd Dermatomycoses Drug Corporation Information
12.3.2 Blueberry Therapeutics Ltd Dermatomycoses Drug Business Overview and Total Revenue
12.3.3 Blueberry Therapeutics Ltd Dermatomycoses Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Blueberry Therapeutics Ltd Dermatomycoses Drug Products Offered
12.3.5 Blueberry Therapeutics Ltd Recent Development
12.4 Daewoong Pharmaceutical Co Ltd
12.4.1 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Corporation Information
12.4.2 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Business Overview and Total Revenue
12.4.3 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Products Offered
12.4.5 Daewoong Pharmaceutical Co Ltd Recent Development
12.5 Dermala Inc
12.5.1 Dermala Inc Dermatomycoses Drug Corporation Information
12.5.2 Dermala Inc Dermatomycoses Drug Business Overview and Total Revenue
12.5.3 Dermala Inc Dermatomycoses Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Dermala Inc Dermatomycoses Drug Products Offered
12.5.5 Dermala Inc Recent Development
12.6 Helix BioMedix Inc
12.6.1 Helix BioMedix Inc Dermatomycoses Drug Corporation Information
12.6.2 Helix BioMedix Inc Dermatomycoses Drug Business Overview and Total Revenue
12.6.3 Helix BioMedix Inc Dermatomycoses Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Helix BioMedix Inc Dermatomycoses Drug Products Offered
12.6.5 Helix BioMedix Inc Recent Development
12.7 Novan Inc
12.7.1 Novan Inc Dermatomycoses Drug Corporation Information
12.7.2 Novan Inc Dermatomycoses Drug Business Overview and Total Revenue
12.7.3 Novan Inc Dermatomycoses Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novan Inc Dermatomycoses Drug Products Offered
12.7.5 Novan Inc Recent Development
12.8 Sol-Gel Technologies Ltd
12.8.1 Sol-Gel Technologies Ltd Dermatomycoses Drug Corporation Information
12.8.2 Sol-Gel Technologies Ltd Dermatomycoses Drug Business Overview and Total Revenue
12.8.3 Sol-Gel Technologies Ltd Dermatomycoses Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Sol-Gel Technologies Ltd Dermatomycoses Drug Products Offered
12.8.5 Sol-Gel Technologies Ltd Recent Development
12.9 TGV-Laboratories
12.9.1 TGV-Laboratories Dermatomycoses Drug Corporation Information
12.9.2 TGV-Laboratories Dermatomycoses Drug Business Overview and Total Revenue
12.9.3 TGV-Laboratories Dermatomycoses Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 TGV-Laboratories Dermatomycoses Drug Products Offered
12.9.5 TGV-Laboratories Recent Development
12.10 Viamet Pharmaceuticals Inc
12.10.1 Viamet Pharmaceuticals Inc Dermatomycoses Drug Corporation Information
12.10.2 Viamet Pharmaceuticals Inc Dermatomycoses Drug Business Overview and Total Revenue
12.10.3 Viamet Pharmaceuticals Inc Dermatomycoses Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Viamet Pharmaceuticals Inc Dermatomycoses Drug Products Offered
12.10.5 Viamet Pharmaceuticals Inc Recent Development
12.11 Vyome Biosciences Pvt Ltd
12.11.1 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Corporation Information
12.11.2 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Business Overview and Total Revenue
12.11.3 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Products Offered
12.11.5 Vyome Biosciences Pvt Ltd Recent Development
13 Dermatomycoses Drug Manufacturing Cost Analysis
13.1 Dermatomycoses Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Dermatomycoses Drug
13.4 Dermatomycoses Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Dermatomycoses Drug Distributors List
14.3 Dermatomycoses Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Dermatomycoses Drug Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Dermatomycoses Drug Sales (K Units) Comparison by Application (2020-2026)
Table 3. Global Market Dermatomycoses Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Dermatomycoses Drug Sales (K Units) by Region (2015-2020)
Table 5. Global Dermatomycoses Drug Sales Market Share by Region (2015-2020)
Table 6. Global Dermatomycoses Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Dermatomycoses Drug Revenue Share by Region (2015-2020)
Table 8. Global Dermatomycoses Drug Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Dermatomycoses Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Dermatomycoses Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Dermatomycoses Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Dermatomycoses Drug (K Units) of Key Companies (2015-2020)
Table 13. Global Dermatomycoses Drug Sales Share by Company (2015-2020)
Table 14. Global Dermatomycoses Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Dermatomycoses Drug Revenue Share by Company (2015-2020)
Table 16. Global Dermatomycoses Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatomycoses Drug as of 2019)
Table 17. Global Dermatomycoses Drug Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Dermatomycoses Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Dermatomycoses Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Dermatomycoses Drug Players
Table 22. Global Dermatomycoses Drug Sales (K Units) by Type (2015-2020)
Table 23. Global Dermatomycoses Drug Sales Share by Type (2015-2020)
Table 24. Global Dermatomycoses Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Dermatomycoses Drug Price (K Units) by Type (2015-2020)
Table 26. Global Dermatomycoses Drug Sales Share by Type (2021-2026)
Table 27. Global Dermatomycoses Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Dermatomycoses Drug Revenue Share by Type (2021-2026)
Table 29. Global Dermatomycoses Drug Price (K Units) by Type (2021-2026)
Table 30. Global Dermatomycoses Drug Sales (K Units) by Application (2015-2020)
Table 31. Global Dermatomycoses Drug Sales Share by Application (2015-2020)
Table 32. Global Dermatomycoses Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Dermatomycoses Drug Price (K Units) by Application (2015-2020)
Table 34. Global Dermatomycoses Drug Sales (K Units) by Application (2021-2026)
Table 35. Global Dermatomycoses Drug Sales Share by Application (2021-2026)
Table 36. Global Dermatomycoses Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Dermatomycoses Drug Revenue Share by Application (2021-2026)
Table 38. Global Dermatomycoses Drug Price (K Units) by Application (2021-2026)
Table 39. United States Dermatomycoses Drug Sales (K Units) by Company (2015-2020)
Table 40. United States Dermatomycoses Drug Sales Market Share by Company (2015-2020)
Table 41. United States Dermatomycoses Drug Sales (K Units) by Type (2015-2020)
Table 42. United States Dermatomycoses Drug Sales Market Share by Type (2015-2020)
Table 43. United States Dermatomycoses Drug Sales (K Units) by Application (2015-2020)
Table 44. United States Dermatomycoses Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Dermatomycoses Drug Sales (K Units) by Company (2015-2020)
Table 46. Europe Dermatomycoses Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Dermatomycoses Drug Sales (K Units) by Type (2015-2020)
Table 48. Europe Dermatomycoses Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Dermatomycoses Drug Sales (K Units) by Application (2015-2020)
Table 50. Europe Dermatomycoses Drug Sales Market Share by Type (2015-2020)
Table 51. China Dermatomycoses Drug Sales (K Units) by Company (2015-2020)
Table 52. China Dermatomycoses Drug Sales Market Share by Company (2015-2020)
Table 53. China Dermatomycoses Drug Sales (K Units) by Type (2015-2020)
Table 54. China Dermatomycoses Drug Sales Market Share by Type (2015-2020)
Table 55. China Dermatomycoses Drug Sales (K Units) by Application (2015-2020)
Table 56. China Dermatomycoses Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Dermatomycoses Drug Sales (K Units) by Company (2015-2020)
Table 58. Japan Dermatomycoses Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Dermatomycoses Drug Sales (K Units) by Type (2015-2020)
Table 60. Japan Dermatomycoses Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Dermatomycoses Drug Sales (K Units) by Application (2015-2020)
Table 62. Japan Dermatomycoses Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Dermatomycoses Drug Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Dermatomycoses Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Dermatomycoses Drug Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Dermatomycoses Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Dermatomycoses Drug Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Dermatomycoses Drug Sales Market Share by Application (2015-2020)
Table 69. India Dermatomycoses Drug Sales (K Units) by Company (2015-2020)
Table 70. India Dermatomycoses Drug Sales Market Share by Company (2015-2020)
Table 71. India Dermatomycoses Drug Sales (K Units) by Type (2015-2020)
Table 72. India Dermatomycoses Drug Sales Market Share by Type (2015-2020)
Table 73. India Dermatomycoses Drug Sales (K Units) by Application (2015-2020)
Table 74. India Dermatomycoses Drug Sales Market Share by Application (2015-2020)
Table 75. Anacor Pharmaceuticals Inc Corporation Information
Table 76. Anacor Pharmaceuticals Inc Description and Business Overview
Table 77. Anacor Pharmaceuticals Inc Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Anacor Pharmaceuticals Inc Dermatomycoses Drug Product
Table 79. Anacor Pharmaceuticals Inc Recent Development
Table 80. Biolab Farmaceutica Ltda Corporation Information
Table 81. Biolab Farmaceutica Ltda Description and Business Overview
Table 82. Biolab Farmaceutica Ltda Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Biolab Farmaceutica Ltda Dermatomycoses Drug Product
Table 84. Biolab Farmaceutica Ltda Recent Development
Table 85. Blueberry Therapeutics Ltd Corporation Information
Table 86. Blueberry Therapeutics Ltd Description and Business Overview
Table 87. Blueberry Therapeutics Ltd Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Blueberry Therapeutics Ltd Dermatomycoses Drug Product
Table 89. Blueberry Therapeutics Ltd Recent Development
Table 90. Daewoong Pharmaceutical Co Ltd Corporation Information
Table 91. Daewoong Pharmaceutical Co Ltd Description and Business Overview
Table 92. Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Product
Table 94. Daewoong Pharmaceutical Co Ltd Recent Development
Table 95. Dermala Inc Corporation Information
Table 96. Dermala Inc Description and Business Overview
Table 97. Dermala Inc Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Dermala Inc Dermatomycoses Drug Product
Table 99. Dermala Inc Recent Development
Table 100. Helix BioMedix Inc Corporation Information
Table 101. Helix BioMedix Inc Description and Business Overview
Table 102. Helix BioMedix Inc Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Helix BioMedix Inc Dermatomycoses Drug Product
Table 104. Helix BioMedix Inc Recent Development
Table 105. Novan Inc Corporation Information
Table 106. Novan Inc Description and Business Overview
Table 107. Novan Inc Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Novan Inc Dermatomycoses Drug Product
Table 109. Novan Inc Recent Development
Table 110. Sol-Gel Technologies Ltd Corporation Information
Table 111. Sol-Gel Technologies Ltd Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Sol-Gel Technologies Ltd Description and Business Overview
Table 113. Sol-Gel Technologies Ltd Dermatomycoses Drug Product
Table 114. Sol-Gel Technologies Ltd Recent Development
Table 115. TGV-Laboratories Corporation Information
Table 116. TGV-Laboratories Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. TGV-Laboratories Description and Business Overview
Table 118. TGV-Laboratories Dermatomycoses Drug Product
Table 119. TGV-Laboratories Recent Development
Table 120. Viamet Pharmaceuticals Inc Corporation Information
Table 121. Viamet Pharmaceuticals Inc Description and Business Overview
Table 122. Viamet Pharmaceuticals Inc Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Viamet Pharmaceuticals Inc Dermatomycoses Drug Product
Table 124. Viamet Pharmaceuticals Inc Recent Development
Table 125. Vyome Biosciences Pvt Ltd Corporation Information
Table 126. Vyome Biosciences Pvt Ltd Description and Business Overview
Table 127. Vyome Biosciences Pvt Ltd Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Vyome Biosciences Pvt Ltd Dermatomycoses Drug Product
Table 129. Vyome Biosciences Pvt Ltd Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Dermatomycoses Drug Distributors List
Table 133. Dermatomycoses Drug Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermatomycoses Drug Product Picture
Figure 2. Global Dermatomycoses Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Dermatomycoses Drug Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Others Examples
Figure 9. Global Dermatomycoses Drug Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Dermatomycoses Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Dermatomycoses Drug Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Dermatomycoses Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Dermatomycoses Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Dermatomycoses Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Dermatomycoses Drug Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Dermatomycoses Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Dermatomycoses Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Dermatomycoses Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Dermatomycoses Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Dermatomycoses Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Dermatomycoses Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Dermatomycoses Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Dermatomycoses Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Dermatomycoses Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Dermatomycoses Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Dermatomycoses Drug Players Market Share by Revenue in Dermatomycoses Drug 2015 & 2019
Figure 27. Dermatomycoses Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Dermatomycoses Drug Revenue Share by Type (2015-2020)
Figure 29. Global Dermatomycoses Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Dermatomycoses Drug Revenue Share by Application (2015-2020)
Figure 31. Global Dermatomycoses Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Dermatomycoses Drug Sales Market Share by Type in 2019
Figure 33. United States Dermatomycoses Drug Sales Market Share by Type in 2019
Figure 34. Europe Dermatomycoses Drug Sales Market Share by Company in 2019
Figure 35. Europe Dermatomycoses Drug Sales Market Share by Type in 2019
Figure 36. Europe Dermatomycoses Drug Sales Market Share by Application in 2019
Figure 37. China Dermatomycoses Drug Sales Market Share by Company in 2019
Figure 38. China Dermatomycoses Drug Sales Market Share by Type in 2019
Figure 39. China Dermatomycoses Drug Sales Market Share by Application in 2019
Figure 40. Japan Dermatomycoses Drug Sales Market Share by Company in 2019
Figure 41. Japan Dermatomycoses Drug Sales Market Share by Type in 2019
Figure 42. Japan Dermatomycoses Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Dermatomycoses Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Dermatomycoses Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Dermatomycoses Drug Sales Market Share by Application in 2019
Figure 46. India Dermatomycoses Drug Sales Market Share by Company in 2019
Figure 47. India Dermatomycoses Drug Sales Market Share by Type in 2019
Figure 48. India Dermatomycoses Drug Sales Market Share by Application in 2019
Figure 49. Anacor Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Biolab Farmaceutica Ltda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Blueberry Therapeutics Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Daewoong Pharmaceutical Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Dermala Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Helix BioMedix Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Novan Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Sol-Gel Technologies Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. TGV-Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Viamet Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Vyome Biosciences Pvt Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Dermatomycoses Drug
Figure 62. Manufacturing Process Analysis of Dermatomycoses Drug
Figure 63. Dermatomycoses Drug Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
象皮病薬の世界市場レポート2020 Market Analysis and Insights: Global Elephantiasis Drug Market The global Elephantiasis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Elephantiasis Drug Scope and Market Size The global Elephantias…- フィブリノーゲン欠乏症薬の世界市場レポート2020 Market Analysis and Insights: Global Fibrinogen Deficiency Drug Market The global Fibrinogen Deficiency Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Fibrinogen Deficiency Drug Scope and Market Siz…
- アレルギー鼻炎薬の世界市場レポート2020 Market Analysis and Insights: Global Allergy Rhinitis Drug Market The global Allergy Rhinitis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Allergy Rhinitis Drug Scope and Market Size The global Al…
- 細菌性赤痢薬の世界市場レポート2020 Market Analysis and Insights: Global Bacillary Dysentery Drug Market The global Bacillary Dysentery Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Bacillary Dysentery Drug Scope and Market Size The …
- 前部ブドウ膜炎薬の世界市場レポート2020 Market Analysis and Insights: Global Anterior Uveitis Drug Market The global Anterior Uveitis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Anterior Uveitis Drug Scope and Market Size The global An…